Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,595 public trials 1,040 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Completed

A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795

NCT00920257

Conditions
Breast Diseases, Breast Neoplasms, Cancer, +21 more
Locations
  • GSK Investigational Site Baltimore, Maryland, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Oklahoma City, Oklahoma, United States
View Trial Details
Completed

Safety, Pharmacokinetics (PK) of AKT and MEK Combination

NCT01138085

Conditions
Breast Diseases, Breast Neoplasms, Cancer, +15 more
Locations
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site New Haven, Connecticut, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Boston, Massachusetts, United States
View Trial Details
Completed

A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer

NCT00937560

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Hospital Amaral Carvalho Jaú, São Paulo, Brazil
  • Hospital das Clinicas - FMUSP, Oncologia São Paulo, Brazil
  • Centre Hospitalier Henri Duffaut; Hematologie Avignon, France
  • Clinique Tivoli; Sce Radiotherapie Bordeaux, France
View all 55 locations
View Trial Details

Related conditions